PGY2 Investigational Drug and Research

The PGY-2 Investigational Drug and Research Pharmacy residency program at UTSW is a one-year post-graduate training program designed to provide an opportunity for the residents to develop strong clinical foundation, knowledge, leadership skills and experience to specialize in clinical research and investigation drug services.


PGY-2 pharmacy residency program will provide residents with opportunities to function as independent practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the program will be prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

PPS Information

UT Southwestern IDR program will be participating in PPS at ASHP Midyear. PPS registration opens Sept. 7, 2022, and interviews will be held Dec. 4-7, 2022, at Midyear. Information for registration and sign-up can be found on the ASHP website “PPS Candidates” page.


Residents will gain experience and training in the following clinical service areas:

  • Orientation
  • Investigational Drug Service Pharmacy Leadership
  • Investigational Drug Service Operations (Oncology)
  • Investigational Drug Service Operations (Non-oncology; ambulatory)
  • Clinical Patient Care
    • Phase 1 Oncology
    • Hematology-Oncology
    • Acute Care
  • Clinical Trial Office (Oncology)
  • Research Quality, Medication Safety and Regulatory Compliance

Elective Rotations

  • Clinical Pharmacology
  • Clinical Trial Office (Non-oncology)
  • Ambulatory Clinical Research (Non-oncology)
  • Clinical Trial Development and Support

Longitudinal Expectations

  • Clinical research study management; Institutional Review Board
  • Staff in investigational drug service
  • Major research project
  • Medication Use Evaluation
  • Precept PGY-1 residents and students

Program Expectations

  • ACPE-accredited CE presentation
  • Major research project and manuscript
  • Present major research project at a regional or national meeting

Current Resident

Christina Baroody

Christina Baroody is a PGY-2 Investigational Drugs and Research Resident at UT Southwestern Medical Center. Dr. Baroody earned her Doctor of Pharmacy from the Lebanese American University, and she completed her PGY-1 Pharmacy Residency at the Lebanese American University Medical Center – Rizk Hospital in Beirut, Lebanon.

She decided to pursue the IDR specialty at UTSW because she is highly interested in clinical research and the development of new drugs. Her pharmacy interests include immunotherapy, cardiology, and clinical trial management.

She is a member of the American Society of Health-System Pharmacists and American College of Clinical Pharmacy. Outside of pharmacy, she enjoys reading, practicing yoga, and exploring new restaurants. Though most of the time, you would probably catch her making phone-calls with friends and family that are overseas.